Other
Matthew Spector
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
Phase 2
3(75.0%)
N/A
1(25.0%)
4Total
Phase 2(3)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT07631650Phase 2Not Yet Recruiting
Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients
Role: lead
NCT07283861Not ApplicableActive Not Recruiting
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
Role: lead
NCT07423078Phase 2Recruiting
Window of Opportunity in Preserving Laryngeal Function Trial
Role: lead
NCT06831149Phase 2Recruiting
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
Role: lead
All 4 trials loaded